CONCERT PHARMACEUTICALS, INC. Annual Operating Income (Loss) in USD from 2012 to 2021

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Concert Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2021.
  • Concert Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$29.6M, a 10.5% decline year-over-year.
  • Concert Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$124M, a 88.1% decline year-over-year.
  • Concert Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$77.5M, a 6.69% decline from 2020.
  • Concert Pharmaceuticals, Inc. annual Operating Income (Loss) for 2020 was -$72.6M, a 8.06% increase from 2019.
  • Concert Pharmaceuticals, Inc. annual Operating Income (Loss) for 2019 was -$79M, a 42.2% decline from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 -$77.5M -$4.86M -6.69% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-03
2020 -$72.6M +$6.37M +8.06% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 -$79M -$23.4M -42.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 -$55.6M -$148M -160% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 $92.6M +$144M Jan 1, 2017 Dec 31, 2017 10-K 2019-02-28
2016 -$51.2M -$76M -306% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $24.8M +$55.4M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 -$30.6M -$26.2M -594% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-06
2013 -$4.41M +$14.2M +76.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-01
2012 -$18.6M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.